August 1997
Clinical & Investigative Medicine;Aug97 Supplement, Vol. 20, pS14
Academic Journal
Presents an abstract of the research manuscript `Immunosuppressive role of IL-10 in contact hypersensitivity is mainly mediated by modulating IL-1alpha and IL-1beta production,' by G.M. Shivji, P. Toto et al from the University of Toronto.


Related Articles

  • Hapten-Specific Tolerance Induced by Acute, Low-Dose Ultraviolet B Radiation of Skin Is Mediated via Interleukin-10. Niizeki, Hironori; Streilein, J. Wayne // Journal of Investigative Dermatology;Jul97, Vol. 109 Issue 1, p25 

    Because interleukin (IL)-10 is an immunoregulatory cytokine that is produced by keratinocytes exposed to UVB radiation (UVR), we determined whether IL-10 participates in either failed contact hypersensitivity (CH) induction or tolerance after acute, low-dose UVR. Murine recombinant IL-10 (200...

  • An Interleukin-1 Genotype Is Associated with Fatal Outcome of Meningococcal Disease. Read, Robert C.; Camp, Nicola J.; di Giovine, Franco S.; Borrow, Raymond; Kaczmarski, Edward B.; Chaudhary, Adeel G. A.; Fox, Andrew J.; Duff, Gordon W. // Journal of Infectious Diseases;11/1/2000, Vol. 182 Issue 5, p1557 

    Reports on the association of interleukin-1 genotype with fatal outcome of meningococcal disease. Linking of composite genotype consisting of heterozygosity of interleukin (IL)-1B and homozygosity of the common allele of the IL-1 receptor antagonist gene with survival; Influence of IL-1...

  • Nerve Growth Factor, Neuropeptides, and Mast Cells in Ultraviolet-B-Induced Systemic Suppression of Contact Hypersensitivity Responses in Mice. Townley, Scott L; Grimbaldeston, Michele A; Ferguson, Ian; Rush, Robert A; Zhang, Shu-Hua; Zhou, Xin-Fu; Conner, James M; Finlay-Jones, John J; Hart, Prue H // Journal of Investigative Dermatology;Mar2002, Vol. 118 Issue 3, p396 

    The induction of systemic immunosuppression following ultraviolet B radiation exposure has been linked with the release of inflammatory and immunomodulatory mediators by cells of the epidermis and dermis. Nerve growth factor has not previously been linked with ultraviolet-B-induced...

  • Interleukin-10 Inhibits the Elicitation Phase of Allergic Contact Hypersensitivity. Kondo, Seiji; McKenzie, Roderick C.; Sauder, Daniel N. // Journal of Investigative Dermatology;Dec94, Vol. 103 Issue 6, p811 

    Interleukin-10 (IL-10) is known to play a major role in suppressing immune and inflammatory responses by inhibiting the production of proinflammatory cytokines. Therefore, we hypothesized that IL-10 might be capable of suppressing allergic contact hypersensitivity. BALB/c mice were sensitized on...

  • In Vivo Effects of Interleukin-10 on Contact Hypersensitivity and Delayed-Type Hypersensitivity Reactions. Schwarz, Agatha; Grabbe, Stephan; Riemann, Helge; Aragane, Yoshinori; Simon, Manuel; Manon, Satish; Andrade, Sylvia; Luger, Thomas A.; Zlotnik, Albert; Schwarz, Thomas // Journal of Investigative Dermatology;Aug94, Vol. 103 Issue 2, p211 

    Interleukin (IL) 10 is a recently discovered cytokine, originally isolated from T-helper 2 (Th2) cells, which inhibits cytokine production of T-helper 1 (Th1) cells. Because Th1 cells appear to be of importance during the contact hypersensitivity reaction (CHS)we hypothesized that IL-10 might...

  • Interleukin-1 Receptor Antagonist Suppresses Contact Hypersensitivity. Kondo, Seiji; Pastore, Saveria; Fujisawa, Hiroshi; Shivji, Gulnar M.; McKenzie, Roderick C.; Dinarello, Charles A.; Sauder, Daniel N. // Journal of Investigative Dermatology;Sep95, Vol. 105 Issue 3, p334 

    Interleukin-1 receptor antagonist (IL-1ra), a naturally occurring inhibitor of interleukin-1 (IL-1), blocks IL-1 binding to its receptors but has no agonistic activity. IL-1 Is thought to play an important role in contact hypersensitivity (CHS), although the effects of exogenously administered...

  • In Vivo Administration of Interleukin 1 to Normal Mice Depresses Their Capacity to Elicit Contact Hypersensitivity Responses: Prostaglandins Are Involved in This Modification of Immune Function. Robertson, Bekkie; Gahring, Lorise; Newton, Robert; Daynes, Raymond // Journal of Investigative Dermatology;Apr87, Vol. 88 Issue 4, p380 

    The administration of pyrogenic doses of interleukin 1 (IL-1) to normal mice before contact sensitization with dinitrofluorobenzene (DNFB) resulted in a significant reduction in the intensity of the elicited contact hypersensitivity (CH) responses. Adoptive transfer experiments established no...

  • Oral Administration of Interleukin-10 and Anti-IL-1 Antibody Ameliorates Experimental Intestinal Inflammation. Cardani, Diego; Dusio, Giuseppina F.; Luchini, Patrizia; Sciarabba, Michele; Solimene, Umberto; Rumio, Cristiano // Gastroenterology Research;Aug2013, Vol. 6 Issue 4, p124 

    Background: To elucidate the effects of a solution containing interleukin-10 and anti-IL-1 antibody in modulating experimental intestinal inflammation. Methods: Colitis was induced in BALB/c mice by oral administration of dextran sodium sulphate; mice were then treated with interleukin-10 plus...

  • Applying patient selection criteria for drotrecogin alfa therapy in practice. Wong-Beringer, Annie; Liao, Cindy; Nguyen, Megan; Pallares, Jean // American Journal of Health-System Pharmacy;7/1/2003, Vol. 60 Issue 13, p1345 

    Severe sepsis is a syndrome estimated to occur in 3 patients out of every 1000 admitted to the hospital. The overall mortality rate for severe sepsis is 30-50%. Severe sepsis is a clinical response to infection mediated by the release of proinflammatory cytokines, including interleukin (IL)-1,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics